Sara Mele
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome during treatment with the bivalent CD20xCD3 bispecific antibody glofitamab.
Journal: Haematologica
Published: December 01, 2025
Nodal Marginal Zone Lymphoma with Prominent Expansion of PD-1+ T-Follicular Helper Cells: A Persistent Diagnostic Challenge with a Heterogeneous Mutational Architecture.
Journal: International journal of molecular sciences
Published: November 21, 2025
The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study.
Journal: Oncoimmunology
Published: June 02, 2025
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: International journal of molecular sciences
Published: February 04, 2025
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
Journal: Cancers
Published: October 13, 2022
Childhood Therapy-Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 27, 2020
Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology.
Journal: Medicina (Kaunas, Lithuania)
Published: May 12, 2019
Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas.
Journal: Frontiers in oncology
Published: December 21, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026